Erste Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $456K | Sell |
|
|||||
|
2025
Q2 | $636K | Buy |
|
|||||
|
2025
Q1 | $568K | Hold |
|
|||||
|
2024
Q4 | $652K | Hold |
|
|||||
|
2024
Q3 | $817K | Hold |
|
|||||
|
2024
Q2 | $622K | Hold |
|
|||||
|
2024
Q1 | $703K | Hold |
|
|||||
|
2023
Q4 | $725K | Hold |
|
|||||
|
2023
Q3 | $528K | Hold |
|
|||||
|
2023
Q2 | $700K | Hold |
|
|||||
|
2023
Q1 | $580K | Hold |
|
|||||
|
2022
Q4 | $678K | Hold |
|
|||||
|
2022
Q3 | $609K | Hold |
|
|||||
|
2022
Q2 | $904K | Hold |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $1.42M | Hold |
|
|||||
|
2021
Q3 | $1.48M | Hold |
|
|||||
|
2021
Q2 | $1.66M | Hold |
|
|||||
|
2021
Q1 | $1.93M | Hold |
|
|||||
|
2020
Q4 | $2.54M | Sell |
|
|||||
|
2020
Q3 | $1.57M | Sell |
|
|||||
|
2020
Q2 | $7.25M | Hold |
|
|||||
|
2020
Q1 | $4.23M | Hold |
|
|||||
|
2019
Q4 | $4.1M | Hold |
|
|||||
|
2019
Q3 | $4.06M | Hold |
|
|||||
|
2019
Q2 | $5.99M | Hold |
|
|||||
|
2019
Q1 | $6.56M | Buy |
|
|||||
|
2018
Q4 | $3.68M | Buy |
|